Kim R - Search Results

1

Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.

Metcalfe K, Huzarski T, Gronwald J, Kotsopoulos J, Kim R, Moller P, Pal T, Aeilts A, Eisen A, Karlan B, Bordeleau L, Tung N, Olopade O, Zakalik D, Singer CF, Foulkes W, Couch F, Neuhausen SL, Eng C, Sun P, Lubinski J, Narod SA; Hereditary Breast Cancer Clinical Study Group. Metcalfe K, et al. Among authors: kim r. Br J Cancer. 2024 Feb;130(2):269-274. doi: 10.1038/s41416-023-02503-8. Epub 2023 Nov 29. Br J Cancer. 2024. PMID: 38030749 Free PMC article.

2

Case Report: Use of Tumor and Germline Y Chromosomal Analysis to Guide Surgical Management in a 46, XX Female Presenting With Gonadoblastoma With Dysgerminoma.

McCuaig JM, Noor A, Rosen B, Casper RF, Mitri F, Colgan T, Kim RH. McCuaig JM, et al. Int J Gynecol Pathol. 2017 Sep;36(5):466-470. doi: 10.1097/PGP.0000000000000349. Int J Gynecol Pathol. 2017. PMID: 28800577

3

BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian Cancer.

Kotsopoulos J, Willows K, Trat S, Kim RH, Volenik A, Sun P, Narod SA, Boyd J, May T. Kotsopoulos J, et al. Int J Gynecol Cancer. 2018 Jan;28(1):69-76. doi: 10.1097/IGC.0000000000001144. Int J Gynecol Cancer. 2018. PMID: 29194191

4

No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.

Jacobson M, Bernardini M, Sobel ML, Kim RH, McCuaig J, Allen L. Jacobson M, et al. J Obstet Gynaecol Can. 2018 Nov;40(11):1497-1510. doi: 10.1016/j.jogc.2018.05.046. J Obstet Gynaecol Can. 2018. PMID: 30473125

5

N^o 366 - Prise en charge gynécologique du cancer du sein et de l'ovaire héréditaire.

Jacobson M, Bernardini M, Sobel ML, Kim RH, McCuaig J, Allen L. Jacobson M, et al. J Obstet Gynaecol Can. 2018 Nov;40(11):1511-1527. doi: 10.1016/j.jogc.2018.09.001. J Obstet Gynaecol Can. 2018. PMID: 30473126

6

Modified panel-based genetic counseling for ovarian cancer susceptibility: A randomized non-inferiority study.

McCuaig JM, Tone AA, Maganti M, Romagnuolo T, Ricker N, Shuldiner J, Rodin G, Stockley T, Kim RH, Bernardini MQ. McCuaig JM, et al. Gynecol Oncol. 2019 Apr;153(1):108-115. doi: 10.1016/j.ygyno.2018.12.027. Epub 2019 Jan 10. Gynecol Oncol. 2019. PMID: 30638766 Clinical Trial.

7

Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system.

McCuaig JM, Care M, Ferguson SE, Kim RH, Stockley TL, Metcalfe KA. McCuaig JM, et al. Gynecol Oncol. 2020 Sep;158(3):747-753. doi: 10.1016/j.ygyno.2020.06.507. Epub 2020 Jul 14. Gynecol Oncol. 2020. PMID: 32674931 Free article.

8

Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.

Care M, McCuaig J, Clarke B, Grenier S, Kim RH, Rouzbahman M, Stickle N, Bernardini M, Stockley TL. Care M, et al. Mol Oncol. 2021 Jan;15(1):80-90. doi: 10.1002/1878-0261.12817. Epub 2020 Oct 22. Mol Oncol. 2021. PMID: 33030818 Free PMC article.

9

The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.

Tone AA, McCuaig JM, Ricker N, Boghosian T, Romagnuolo T, Stickle N, Virtanen C, Zhang T, Kim RH, Ferguson SE, May T, Laframboise S, Armel S, Demsky R, Volenik A, Stuart-McEwan T, Shaw P, Oza A, Kamel-Reid S, Stockley T, Bernardini MQ. Tone AA, et al. Among authors: kim rh. Gynecol Oncol. 2021 Jul;162(1):97-106. doi: 10.1016/j.ygyno.2021.04.011. Epub 2021 Apr 13. Gynecol Oncol. 2021. PMID: 33858678

10

Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.

Xia YY, Gronwald J, Karlan B, Lubinski J, McCuaig JM, Brooks J, Moller P, Eisen A, Sun S, Senter L, Bordeleau L, Neuhausen SL, Singer CF, Tung N, Foulkes WD, Sun P, Narod SA, Kotsopoulos J; Hereditary Ovarian Cancer Clinical Study Group. Xia YY, et al. Gynecol Oncol. 2022 Mar;164(3):514-521. doi: 10.1016/j.ygyno.2022.01.014. Epub 2022 Jan 19. Gynecol Oncol. 2022. PMID: 35063280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,830 results

Search Page

Filters